Acino Pharma AG
Acino Pharma AG is a CDMO company based in Aesch (Basel-Landschaft) recorded by Swissmedic as the authorisation holder for 29 human medicines. That places it 58 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | CDMO |
|---|---|
| City | Aesch |
| Canton | Basel-Landschaft |
| Authorisation holder | Yes |
| Medicines | 29 |
| Founded | Not available |
| Employees | 201-1000 |
| Parent group | Acino International AG |
| Activity | Not available |
| Website | acino.swiss |
Medicines authorised in Switzerland
Acino Pharma AG is recorded by Swissmedic as the authorisation holder for 29 human medicines. The table shows 29 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
29 of 29 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Amlodipin-Acino 5 mg | 57678 | B | C08CA01 | 2007-05-11 |
| Bactiflox 500 | 56939 | A | J01MA02 | 2005-04-26 |
| Cefuroxim-Acino 250 mg | 62774 | A | J01DC02 | 2012-07-02 |
| Clopidogrel-Acino 75 | 60101 | B | B01AC04 | 2010-03-19 |
| CoAmox-Acino 1000 | 62850 | A | - | 2013-03-25 |
| CoAmox-Acino 457 | 62747 | A | - | 2012-06-06 |
| Decatylen neo | 50018 | D | R02AA02 | 1988-12-19 |
| Dexlansoprazole-Acino 30 mg | 67981 | B | - | 2020-09-16 |
| Diclo-Acino 10 mg/g | 62771 | D | M02AA15 | 2012-08-29 |
| Diclo-Acino 100 retard | 62730 | B | M01AB05 | 2012-10-19 |
| Diclo-Acino 140 mg/140 cm² | 62770 | D | M02AA15 | 2012-07-26 |
| Diclo-Acino 25 | 62728 | B | M01AB05 | 2012-10-19 |
| Diclo-Acino 75 | 62735 | B | M01AB05 | 2012-08-29 |
| Diclo-Acino 75 retard | 62731 | B | M01AB05 | 2012-10-19 |
| Fluoxetin-Acino 20 mg | 62759 | B | - | 2012-07-20 |
| Itracim | 57544 | B | J02AC02 | 2006-09-04 |
| Levacin 100/25 | 57674 | B | N04BA02 | 2009-05-28 |
| Levofloxacin-Acino 250 | 63287 | A | - | 2013-11-12 |
| Metoprolol-Acino 25 | 59206 | B | C07AB02 | 2010-07-02 |
| Neurorubin | 31151 | B | A11DB | 1964-11-10 |
| Nitrofurantoin-Acino 100 retard | 62724 | B | J01XE01 | 2012-05-24 |
| Pantoprazole-Acino 20 mg | 67982 | B | A02BC02 | 2020-09-16 |
| Pantoprazole-Acino i.v. | 67985 | B | A02BC02 | 2020-09-16 |
| Paraconica 1 g I.V. | 62711 | B | N02BE01 | 2013-10-18 |
| Simepar-Acino | 38625 | B | A05BA03 | 1976-12-10 |
| Trabar 100 | 52788 | A | - | 1997-05-22 |
| Trabar 50 | 52787 | A | - | 1994-08-18 |
| Vitamin B1/6/12-Acino | 62736 | B | - | 2012-07-27 |
| Xylo-Acino 0.05 % | 62745 | D | R01AA07 | 2012-07-30 |
Frequently asked questions
How many medicines does Acino Pharma AG have authorised in Switzerland?
Acino Pharma AG is recorded by Swissmedic as the authorisation holder for 29 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Acino Pharma AG based?
The Swiss location recorded for Acino Pharma AG is Aesch, Basel-Landschaft.
Is Acino Pharma AG a Swissmedic authorisation holder?
Yes. Acino Pharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.